KM Research Hub
← 返回结果库查看论文详情PubMed ↗
READ-ONLY DIGITIZATION RESULT

Pirtobrutinib Versus Ibrutinib in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.

J Clin Oncol · 2026-Feb-20 · PMID 41353787

Panel C质量警告待 EXE 对齐验证

PFS

Kaplan-Meier curve of PFS assessed by investigator in the (A) ITT, (B), R/R, and (C) TN populations and by IRC in the (D) ITT population. *Two-sided P values are based on the stratified log-rank test and are reported as nominal values for investigator-assessed PFS. HR, hazard ratio; IRC, independent review committee; ITT, intention to treat; PFS, progression-free survival; R/R, relapsed/refractory; TN, treatment-naïve.

算法:legacy-0.5.0引擎:enhanced-linux
质量评分1.00
质量通过否
预期曲线2
实际曲线1
X 范围-
Y 范围-

曲线数据

网页最多预览 200 行,完整数据请下载 CSV 或 JSON。

当前面板没有可预览的 `curves_mapped.csv` 数据。
历史版本(1)

重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。

版本状态验证曲线时间
legacy-0.5.0quality_warning待验证12026-07-14T12:20:16+00:00